Absci Corp (ABSI)
4.21
-0.04
(-0.94%)
USD |
NASDAQ |
May 31, 16:00
4.19
-0.02
(-0.48%)
After-Hours: 20:00
Absci Net Income (Quarterly): -21.98M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -21.98M |
December 31, 2023 | -23.54M |
September 30, 2023 | -21.99M |
June 30, 2023 | -41.67M |
March 31, 2023 | -23.36M |
December 31, 2022 | -19.47M |
September 30, 2022 | -27.26M |
June 30, 2022 | -28.68M |
March 31, 2022 | -29.49M |
Date | Value |
---|---|
December 31, 2021 | -25.17M |
September 30, 2021 | -23.63M |
June 30, 2021 | -41.20M |
March 31, 2021 | -10.96M |
December 31, 2020 | -4.939M |
September 30, 2020 | -3.748M |
June 30, 2020 | -3.008M |
March 31, 2020 | -2.658M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-41.67M
Minimum
Jun 2023
-2.658M
Maximum
Mar 2020
-20.75M
Average
-23.36M
Median
Mar 2023
Net Income (Quarterly) Benchmarks
Eli Lilly and Co | 2.243B |
Creative Medical Technology Holdings Inc | -1.042M |
CytomX Therapeutics Inc | 13.79M |
Bristol-Myers Squibb Co | -11.91B |
Recursion Pharmaceuticals Inc | -91.37M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 0.898M |
Total Expenses (Quarterly) | 24.40M |
EPS Diluted (Quarterly) | -0.22 |
Enterprise Value | 321.59M |
Profit Margin (Quarterly) | -2.45K% |
Earnings Yield | -27.55% |
Normalized Earnings Yield | -23.19 |